Related references
Note: Only part of the references are listed.1-Methyl-1,2,3,4-Tetrahydroisoquinoline, an Endogenous Amine with Unexpected Mechanism of Action: New Vistas of Therapeutic Application
Lucyna Antkiewicz-Michaluk et al.
NEUROTOXICITY RESEARCH (2014)
Antidepressant-like activity of the endogenous amine, 1-methyl-1,2,3,4-tetrahydroisoquinoline in the behavioral despair test in the rat, and its neurochemical correlates: A comparison with the classical antidepressant, imipramine
Agnieszka Wasik et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease
Valeria S. Fernandes et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness
Michael Maes et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Antioxidative enzymes and increased oxidative stress in depressive women
Jana Kodydkova et al.
CLINICAL BIOCHEMISTRY (2009)
Nonmotor Symptoms of Parkinson's Disease Revealed in an Animal Model with Reduced Monoamine Storage Capacity
Tonya N. Taylor et al.
JOURNAL OF NEUROSCIENCE (2009)
1-Benzyl-1,2,3,4-Tetrahydroisoquinoline, an Endogenous Parkinsonism-Inducing Toxin, Strongly Potentiates MAO-Dependent Dopamine Oxidation and Impairs Dopamine Release: Ex vivo and In vivo Neurochemical Studies
Agnieszka Wasik et al.
NEUROTOXICITY RESEARCH (2009)
Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia
Yukinori Nagakura et al.
PAIN (2009)
Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice
Fraser Murray et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
A mouse model of depression induced by repeated corticosterone injections
Yunan Zhao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Memory impairment induced by low doses of reserpine in rats: Possible relationship with emotional processing deficits in Parkinson disease
Valria S. Fernandes et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Altered vesicular dopamine storage in Parkinson's disease: a premature demise
W. Michael Caudle et al.
TRENDS IN NEUROSCIENCES (2008)
Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration
W. Michael Caudle et al.
JOURNAL OF NEUROSCIENCE (2007)
Non-motor dysfunction in Parkinson's disease
Tjalf Ziemssen et al.
PARKINSONISM & RELATED DISORDERS (2007)
The mechanism of 1,2,3,4-tetrahydroisoquinolines neuroprotection: the importance of free radicals scavenging properties and inhibition of glutamate-induced excitotoxicity
L Antkiewicz-Michaluk et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment
JF Cryan et al.
PSYCHOPHARMACOLOGY (2005)
Central monoamines and their role in major depression
AS Elhwuegi
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice:: comparative study with desipramine, fluvoxamine, venlafaxine and opiates
MO Rojas-Corrales et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2004)
Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties
L Antkiewicz-Michaluk et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Antidepressants: past, present and future
J Vetulani et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Share Paper
